What Researchers Did
Researchers reviewed existing studies to see how hyperbaric oxygen therapy affects heart damage and inflammation markers in adults.
What They Found
Five clinical studies involving 431 patients showed that hyperbaric oxygen therapy (HBOT) reduced CPK levels by up to 35% and improved heart function in acute heart attacks. HBOT also lowered inflammation and heart damage markers after cardiac surgery and reduced inflammatory markers in chronic heart disease.
What This Means for Canadian Patients
This research suggests potential benefits of HBOT for various heart conditions, including reducing heart damage and inflammation. While not a current standard treatment, these findings could encourage future research into HBOT as a supportive therapy for Canadian patients with heart issues.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study's findings are limited because researchers could not combine data statistically due to differences between studies and missing information.